Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Integral Diagnostics' major shareholders revealed, Yarra Funds leads with 6.7% stake

EditorAmbhini Aishwarya
Published 03/10/2023, 04:26 pm
© Reuters.
IDX
-
0P000078WT
-
0P00007E9H
-

Integral Diagnostics Limited's shareholder structure has been divulged, revealing that the company's significant 58% stake is held by individual investors. Meanwhile, institutional investors hold a 32% stake in the company, as reported on Tuesday.

The majority ownership of the company, constituting 41%, is shared among 25 investors. Leading the pack is Yarra Funds Management Limited, holding the largest share at 6.7%. Following closely are the second and third-largest shareholders, owning about 6.1% and 5.5% of the company, respectively.

Institutional investors maintain a respectable stake in Integral Diagnostics, despite potential risks such as share price drops from simultaneous large-scale sell-offs. Their continued investment in the company indicates credibility and confidence in its performance, even in light of occasional bad investments.

The company's inclusion in major indices also plays a significant role in attracting these institutional investors. It underscores the importance of considering Integral Diagnostics' past earnings trajectory when making investment decisions.

According to InvestingPro data, the company has a market cap of $4.32 million and a revenue of $37.37 million as of Q2 2023. The revenue growth has been accelerating, witnessing a quarterly growth of 49.1% in FY2023.Q2. This aligns with one of the InvestingPro Tips that suggests the company's revenue growth has been on the rise.

Moreover, the company's gross profit margin stands at a solid 60.36%. However, it's essential to note that the company has been quickly burning through cash, as pointed out by an InvestingPro Tip. This is reflected in the negative return on assets of -59.29% in Q2 2023.

In terms of share performance, the company has seen a significant return over the last week, with a 10.49% increase. Yet, the overall performance over the past year has been less impressive, with a decrease of -53.27%.

For more insights and tips, consider exploring the InvestingPro product that includes additional tips. For instance, there are currently four more tips available for Integral Diagnostics Limited on InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.